Junctional tachycardia medical therapy

	Junctional tachycardia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Junctional tachycardia from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Endoscopy
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Junctional tachycardia medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Junctional tachycardia medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
Guidance
FDA on Junctional tachycardia medical therapy
on Junctional tachycardia medical therapy
Junctional tachycardia medical therapy in the news
Blogs on Junctional tachycardia medical therapy
Directions to Hospitals Treating Junctional tachycardia
Risk calculators and risk factors for Junctional tachycardia medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Treatment consists of supportive care or correction of the underlying disorder that triggered the junctional automaticity.
Treat symptomatic digitalis toxicity with atropine and digoxin immune Fab (Digibind)